Cargando…

First-in-class positron emission tomography tracer for the glucagon receptor

ABSTRACT: The glucagon receptor (GCGR) is emerging as an important target in anti-diabetic therapy, especially as part of the pharmacology of dual glucagon-like peptide-1/glucagon (GLP-1/GCG) receptor agonists. However, currently, there are no suitable biomarkers that reliably demonstrate GCG recept...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velikyan, Irina, Haack, Torsten, Bossart, Martin, Evers, Andreas, Laitinen, Iina, Larsen, Philip, Plettenburg, Oliver, Johansson, Lars, Pierrou, Stefan, Wagner, Michael, Eriksson, Olof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377692/ https://www.ncbi.nlm.nih.gov/pubmed/30771019 http://dx.doi.org/10.1186/s13550-019-0482-0

Ejemplares similares

Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primates
por: Eriksson, Olof, et al.
Publicado: (2019)

Automated GMP-Compliant Production of [(68)Ga]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans
por: Wagner, Michael, et al.
Publicado: (2020)

Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences
por: Velikyan, Irina, et al.
Publicado: (2022)

Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes
por: Eriksson, Olof, et al.
Publicado: (2020)

Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes
por: Eriksson, Olof, et al.
Publicado: (2022)

A computerized Infusion Pump for control of tissue tracer concentration during Positron Emission Tomography in vivo Pharmacokinetic/Pharmacodynamic measurements
por: Eriksson, Olof, et al.
Publicado: (2008)

Tau Filaments and the Development of Positron Emission Tomography Tracers
por: Goedert, Michel, et al.
Publicado: (2018)

Novel Positron Emission Tomography Tracers for Imaging Vascular Inflammation
por: Ćorović, Andrej, et al.
Publicado: (2020)

Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia
por: Ni, Ruiqing, et al.
Publicado: (2022)

Tracers progress for positron emission tomography imaging of glial-related disease
por: Jia, Haoran, et al.
Publicado: (2022)

Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics
por: Velikyan, Irina, et al.
Publicado: (2020)

Radiotracers for Imaging of Fibrosis: Advances during the Last Two Decades and Future Directions
por: Eriksson, Olof, et al.
Publicado: (2023)

Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose
por: Zhu, Jing, et al.
Publicado: (2022)

Compelling Case for Fostering Titanium-45 for Positron Emission Tomography Tracer Applications
por: Ramamoorthy, Natesan
Publicado: (2020)

Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma
por: Moreau, Aurélie, et al.
Publicado: (2019)

Head-to-head comparison of tau positron emission tomography tracers [(18)F]flortaucipir and [(18)F]RO948
por: Smith, Ruben, et al.
Publicado: (2019)

Development of the First Potential Nonpeptidic Positron Emission Tomography Tracer for the Imaging of CCR2 Receptors
por: Wagner, Stefan, et al.
Publicado: (2020)

Positron Emission Tomography to Assess the Outcome of Intraportal Islet Transplantation
por: Eriksson, Olof, et al.
Publicado: (2016)

Autoradiography screening of potential positron emission tomography tracers for asymptomatic abdominal aortic aneurysms
por: Tegler, Gustaf, et al.
Publicado: (2014)

Discordant findings of different positron emission tomography/CT tracers in a case of glioblastoma
por: Kumar, Ram Elumalai, et al.
Publicado: (2021)

Identification of positron emission tomography (PET) tracer candidates by prediction of the target-bound fraction in the brain
por: Fridén, Markus, et al.
Publicado: (2014)

Biological principles and clinical application of positron emission tomography-tracers in prostate cancer: a review
por: Machado Rocha, José M., et al.
Publicado: (2019)

Ultrafast Photoclick Reaction for Selective (18)F-Positron Emission Tomography Tracer Synthesis in Flow
por: Fu, Youxin, et al.
Publicado: (2021)

Biodistribution and radiation dosimetry of multiple tracers on total-body positron emission tomography/computed tomography
por: Li, Lianghua, et al.
Publicado: (2023)

Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography
por: Schöll, Michael, et al.
Publicado: (2015)

Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors
por: Sun, Aixia, et al.
Publicado: (2018)

Usefulness of Brain Positron Emission Tomography with Different Tracers in the Evaluation of Patients with Idiopathic Normal Pressure Hydrocephalous
por: Mattoli, Maria Vittoria, et al.
Publicado: (2020)

Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma
por: Kuriyama, Kengo, et al.
Publicado: (2020)

Development of a blood sample detector for multi-tracer positron emission tomography using gamma spectroscopy
por: Velasco, Carlos, et al.
Publicado: (2019)

The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor
por: Högnäsbacka, Antonia, et al.
Publicado: (2022)

Species differences in pancreatic binding of DO3A-VS-Cys(40)-Exendin4
por: Eriksson, Olof, et al.
Publicado: (2017)

A Practical One-Pot Synthesis of Positron Emission Tomography (PET) Tracers via Nickel-Mediated Radiofluorination
por: Zlatopolskiy, Boris D, et al.
Publicado: (2015)

A Practical One-Pot Synthesis of Positron Emission Tomography (PET) Tracers via Nickel-Mediated Radiofluorination
por: Zlatopolskiy, Boris D, et al.
Publicado: (2015)

Multiple positron emission tomography tracers for use in the classification of gliomas according to the 2016 World Health Organization criteria
por: Miyake, Keisuke, et al.
Publicado: (2020)

[(18)F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma
por: Valtorta, Silvia, et al.
Publicado: (2021)

Oligometastatic Prostate Cancer Treated with Metastasis-Directed Therapy Guided by Positron Emission Tomography: Does the Tracer Matter?
por: Lanfranchi, Francesco, et al.
Publicado: (2023)

Spatiotemporal patterns of putaminal dopamine processing in Parkinson’s disease: A multi-tracer positron emission tomography study
por: Fu, Jessie Fanglu, et al.
Publicado: (2022)

Improved Radiolytic Stability of a (68)Ga-labelled Collagelin Analogue for the Imaging of Fibrosis
por: Velikyan, Irina, et al.
Publicado: (2021)

Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers
por: Yudistiro, Ryan, et al.
Publicado: (2016)

Development of a highly-specific (18)F-labeled irreversible positron emission tomography tracer for monoacylglycerol lipase mapping
por: Chen, Zhen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_02i6dtdv8r4vsd6apchcdkvibq